Recent 8-K filings for BOLT

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 20:05 UTC earnings item 2.02item 9.01

  Bolt Biotherapeutics reports Q1 2026 results; cash $23.9M, BDC-4182 data expected Q3 2026

source · BOLT on sec.gov